Paragon Bioservices

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Catalent makes all-cash purchase of Paragon Bioservices

The CDMO will spend US$1.2 billion to purchase the viral vector producer, with further investment spent on capital expansion projects already underway
Pharmaceutical

Paragon Bioservices appoints Bill Thomas as Chief Technology Officer

Vaccines industry veteran was most recently with MassBiologics
Manufacturing

Paragon Bioservices hires new VP of Quality

Experienced microbiologist Carolyn Phillips joins the US CDMO
Manufacturing

Paragon Bioservices wins US$15m filovirus vaccine contract

Awarded by the US Department of Defense
Subscribe now